S.3187 - Synthetic Drug Abuse Prevention Act of 2012
A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. view all titles (24)
All Bill Titles
- Short: Synthetic Drug Abuse Prevention Act of 2012 as passed senate.
- Short: Prescription Drug User Fee Amendments of 2012 as passed senate.
- Short: Medical Device User Fee Amendments of 2012 as passed senate.
- Short: Generic Drug User Fee Amendments of 2012 as passed senate.
- Short: Biosimilar User Fee Act of 2012 as passed senate.
- Short: Food and Drug Administration Safety and Innovation Act as passed senate.
- Short: Synthetic Drug Abuse Prevention Act of 2012 as passed house.
- Short: Prescription Drug User Fee Amendments of 2012 as passed house.
- Short: Medical Device User Fee Amendments of 2012 as passed house.
- Short: Generic Drug User Fee Amendments of 2012 as passed house.
- Short: Biosimilar User Fee Act of 2012 as passed house.
- Short: Food and Drug Administration Safety and Innovation Act as passed house.
- Official: A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. as introduced.
- Short: Food and Drug Administration Safety and Innovation Act as introduced.
- Short: Biosimilar User Fee Act of 2012 as introduced.
- Short: Generic Drug User Fee Amendments of 2012 as introduced.
- Short: Medical Device User Fee Amendments of 2012 as introduced.
- Short: Prescription Drug User Fee Amendments of 2012 as introduced.
- Short: Food and Drug Administration Safety and Innovation Act as enacted.
- Short: Biosimilar User Fee Act of 2012 as enacted.
- Short: Generic Drug User Fee Amendments of 2012 as enacted.
- Short: Medical Device User Fee Amendments of 2012 as enacted.
- Short: Prescription Drug User Fee Amendments of 2012 as enacted.
- Short: Synthetic Drug Abuse Prevention Act of 2012 as enacted.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
| All Actions | |
|---|---|
| May 15th | Introduced in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time. |
| May 15th | Introduced in Senate |
| May 16th | Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 400. |
| May 17th | Cloture motion on the motion to proceed to the measure presented in Senate. |
| May 17th | Motion to proceed to consideration of measure made in Senate. |
| May 21st | Cloture motion on the motion to proceed to the measure withdrawn by unanimous consent in Senate. |
| May 21st | Motion to proceed to consideration of measure made in Senate. |
| May 22nd | Motion to proceed to consideration of measure made in Senate. |
| May 23rd | Measure laid before Senate by motion. |
| May 23rd | Motion to proceed to consideration of measure agreed to in Senate by Unanimous Consent. |

U.S. Congress - S.3187 Synthetic Drug Abuse Prevention Act of 2012



